| 证券代码：688268 | 证券简称：华特气体 | 公告编号：2025-068 | | --- | --- | --- | | 转债代码：118033 | 转债简称：华特转债 | | 广东华特气体股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 12 月 4 日 （二） 股东会召开的地点：广东省佛山市南海区里水镇和顺逢西村文头岭脚东 侧广东华特气体股份有限公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 105 | | --- | --- | | 普通股股东人数 | 105 | | 2、出席会议的股东所持有的表决权数量 | 51,382,885 | | 普通股股东所持有表决权数量 | 51,382,885 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的 ...

股东会法律意见书 : 律师能够 DIAI. LAW FIR 2025 年第二次临时股东会的法律意见书 信达科会字(2025)第 058号 致:广东华特气体股份有限公司 中国深圳市福田区益田路 6001 号太平金融大厦 11、12 楼 邮编: 518038 I 1-12/F, TAIPING FINANCE TOWER, YITIAN ROAD 6001, FUTIAN DISTRICT, SHENZHEN, P.R. CHINA 电话(Tel):(0755)88265288 传真(Fax):(0755)88265537 电子邮件(E-mail): info@sundiallawfirm.com 网址(Website): www.sundiallawfirm.com 广东信达律师事务所 关于广东华特气体股份有限公司 广东信达律师事务所(以下简称"信达")接受广东华特气体股份有限公司 (以下简称"公司")的委托,指派信达律师出席公司 2025年第二次临时股东 会(以下简称"本次股东会"),对本次股东会的合法性进行见证,并出具《广 东信达律师事务所关于广东华特气体股份有限公司 2025年第二次临时股东会的 法律意见 ...

证券之星消息，11月25日，华特气体（688268）融资买入2919.55万元，融资偿还2863.31万元，融资净 买入56.23万元，融资余额4.16亿元，近3个交易日已连续净买入累计1286.94万元。 小知识 融券方面，当日无融券交易。 融资融券：融资余额增加反映市场做多情绪强化，融资余额减少反映市场观望情绪或者看空情绪强化； 相应的，融券余额增加反映市场看空情绪增强，融券余额减少反映市场观望情绪增强或者看多情绪增 强。需注意的是，由于融资融券的财务杠杆效应，融资融券对投资者来说也是一把双刃剑，好比放大镜 一般，盈利情况下，利润会成倍增长，亏了也能把亏损放大很多。 融资融券余额4.16亿元，较昨日上涨0.13%。 | 交易日 | 两融余额(元) | 余额变动 (元) | 变动幅度 | | --- | --- | --- | --- | | 2025-11-25 | 4.16亿 | 55.76万 | 0.13% | | 2025-11-24 | 4.16亿 | 876.88万 | 2.15% | | 2025-11-21 | 4.07亿 | 354.00万 | 0.88% | | 2025-11-20 | ...

证券日报网讯华特气体11月25日在互动平台回答投资者提问时表示，2025年10月31日公司股东人数为 13399户。 （文章来源：证券日报） ...

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Core Viewpoint - The company, Huate Gas, has initiated a significant lawsuit regarding a share transfer dispute, seeking a breach of contract penalty of 180 million RMB [1][3]. Group 1: Lawsuit Details - The lawsuit has been filed against Lai Minggui, Sichuan Zhongfu Energy New Materials Technology Co., Ltd., and Luo Jun, and has been accepted by the Intermediate People's Court of Foshan, Guangdong Province [1]. - The core of the lawsuit revolves around the pursuit of breach of contract responsibilities, involving a substantial amount [1][3]. - The company emphasizes that the dispute arises from disagreements during the execution of the share transfer agreement, and the case is currently in the pre-litigation asset preservation and formal filing stage [3]. Group 2: Financial Implications - Huate Gas is requesting the court to order the defendants to pay a penalty of 180 million RMB, along with all litigation costs, including case acceptance and preservation fees [3]. - The company has indicated that it is currently difficult to accurately assess the potential liabilities and economic consequences of the case, and the impact on current and future profits remains uncertain [3]. Group 3: Operational Impact - The company reassures that its production and operational activities are continuing normally and that the lawsuit will not have a substantial impact on daily operations [3]. - Huate Gas plans to strengthen contract management and compliance risk control, while advising investors to rationally assess the uncertainties associated with the lawsuit [3].

Core Viewpoint - Huate Gas has filed a significant lawsuit regarding a share transfer dispute, with the amount involved reaching 180 million yuan, and the case has been accepted by the court but has not yet been heard [1] Group 1: Lawsuit Details - The plaintiff in the lawsuit is Huate Gas, while the defendants include Lai Minggui, Sichuan Zhongfu Energy New Materials Technology Co., Ltd., and Luo Jun [1] - The lawsuit stems from a series of cooperation agreements signed in 2022, including a key agreement that granted Huate Gas exclusive rights to certain gas interests and stipulated a penalty of 180 million yuan for breaches [1] - A supplementary agreement was signed in October 2022, which established joint liability for Luo Jun and Zhongfu Energy regarding the performance of the cooperation agreement [1] Group 2: Allegations of Breach - Huate Gas discovered multiple breaches by Lai Minggui, including participation in a third-party bidding process for NF3 and selling NF3 to other parties, violating the exclusivity agreement [2] - Additional breaches included delays in project commencement, failure to provide accurate project progress updates, and unilateral requests to terminate the cooperation agreement, which Huate Gas deemed as substantial breaches [2] - Huate Gas has previously filed a lawsuit against Lai Minggui for some of these breaches, and this current lawsuit addresses further violations, seeking 180 million yuan in penalties and joint liability from the other defendants [2] Group 3: Legal Proceedings and Financial Impact - Huate Gas has applied for property preservation measures to protect its legal rights and prevent the concealment or transfer of assets during the litigation process [2] - The company has received confirmation from the court regarding the completion of property preservation measures and has disclosed the lawsuit after the reason for delayed disclosure was resolved [3] - The case has not yet been heard, and the final judgment remains uncertain, making it difficult for the company to predict the impact on current or future profits [3]

华特气体公告，公司诉赖明贵、四川中氟能新材料科技有限公司、罗君股权转让纠纷一案已由广东省佛 山市中级人民法院立案受理。公司要求被告支付违约金人民币1.8亿元，并承担案件受理费、保全费等 全部诉讼费用。目前诉讼尚未开庭审理，判决结果不确定，无法预计对公司本期利润或期后利润的影 响。 ...

| | | 广东华特气体股份有限公司 关于提起重大诉讼的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 案件所处的诉讼阶段：已立案受理，尚未开庭审理 上市公司所处的当事人地位：广东华特气体股份有限公司（以下简称"公 司"）为原告 涉案的金额：人民币 1.8 亿元 是否会对上市公司损益产生负面影响：本次诉讼尚未开庭审理，最终的 判决结果尚不确定，目前无法预计对公司本期利润或期后利润的影响，最终实际 影响需以法院生效判决结果为准。公司将根据相关诉讼进展情况及时履行信息披 露义务，敬请投资者注意投资风险。 一、本次诉讼的基本情况 截止本公告披露日，该案件已立案受理，尚未开庭审理。 二、诉讼案件的基本情况 （一）诉讼当事人 原告：广东华特气体股份有限公司 被告一：赖明贵 被告二：四川中氟能新材料科技有限公司（以下简称"中氟能公司"） 被告三：罗君 2025 年 11 月 10 日，公司收到广东省佛山市中级人民法院送达的关于公司 诉赖明贵、四川中氟能新材料科技有限公司、罗君股权转让纠纷一案的《受理案 件通知书》 ...

Core Viewpoint - The investigation into the "12·4" major collapse accident of the Shenzhen-Jiangmen Railway revealed that the accident was caused by violations in construction practices and inadequate emergency response measures, leading to significant casualties and economic losses [2][3]. Group 1: Accident Details - The collapse occurred on December 4, 2024, resulting in 13 fatalities and direct economic losses of approximately 72.61 million yuan [2]. - The direct cause of the accident was identified as the failure to halt excavation when encountering a high-risk geological area, leading to a partial collapse of the tunnel face [2][3]. Group 2: Responsibility and Management Issues - The investigation found that multiple parties, including China Railway Fourth Engineering Group Co., Ltd. (中铁四局), Xiamen-Shenzhen Railway Guangdong Co., Ltd. (厦深公司), and others, failed in their management and risk control responsibilities [3][4]. - The supervising unit, Guangzhou Supervision Station, and the industry regulatory body, Guangzhou Railway Supervision Administration, were also found lacking in their oversight duties [3][4]. Group 3: Lessons Learned and Recommendations - Six major lessons were identified, including failures in risk prevention, monitoring, and emergency response systems, as well as the dangers of proceeding with construction before design changes [5]. - Six recommendations were proposed to improve safety, including enhancing risk prevention measures, strengthening construction safety protocols, and improving emergency response capabilities [5].